Clinical Trial Update: Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer

View source ↗

Summary

Ongoing MD Anderson trial investigating temporal immunologic changes following hypofractionated radiation-induced DNA damage in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Invasive Breast Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Carcinoma, Invasive Breast Carcinoma | Status: RECRUITING